← Open Payments lookup

JON HAUTZENROEDER: Open Payments

NPI 1205300886 · AURORA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$418 in 24 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $33 · 2025 $418

Food & beverage: $418
CompanyPaymentsAmount
ABBVIE INC.9$155
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$65
PFIZER INC.3$49
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$37
Amgen Inc.2$30
Neurocrine BioSciences, Inc.1$20
Novo Nordisk Inc1$16
Bayer Healthcare Pharmaceuticals Inc.1$16
Esperion Therapeutics, Inc.1$15
AstraZeneca Pharmaceuticals LP1$14

Products named: VRAYLAR, CAPLYTA, NURTEC ODT, XIFAXAN, QULIPTA, INGREZZA, Ozempic, Kerendia.

Industry payments across IN — which companies pay providers there.